Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence

Infection and Immunity

Volumn 65, Issue 9, 1997, Pages 3529-3538

  Hube, Bernhard ^a,b   Sanglard, Dominique ^c   Odds, Frank C ^d   Hess, Daniela ^b   Monod, Michel ^c   Schäfer, Wilhelm ^b   Brown, Alistair J P ^a   Gow, Neil A R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF HAMBURG   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; FUNGAL PROTEIN;

ARTICLE; CANDIDA ALBICANS; FUNGUS GROWTH; GENE DISRUPTION; GENE EXPRESSION; MULTIGENE FAMILY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; STRAIN DIFFERENCE; VIRULENCE; YEAST;

EID: 0030884478     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.9.3529-3538.1997     Document Type: Article

References (66)

1. Akiyama, K., T. Shida, H. Yasueda, H. Mita, T. Yamamoto, and H. Yamaguchi. 1994. Atopic asthma caused by Candida albicans acid protease: case reports. Allergy 49:778-781.
2. Bodey, G. P. (ed.). 1993. Candidiasis. Pathogenesis, diagnosis, and treatment, 2nd ed. Raven Press, New York, N.Y.
3. Boeke, J. D., F. Lagroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197:345-346.
4. Borg, M., and R. Rüchel. 1988. Expression of extracellular proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56:626-631.
5. Cassone, A., F. DeBernardis, F. Mondello, T. Ceddia, and L. Agatensi. 1987. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J. Infect. Dis. 156:777-783.
6. Colina, A.-R., F. Aumont, N. Deslauriers, P. Belhumeur, and L. De Repenigny. 1996. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infec. Immun. 64:4514-4514.
7. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
8. DeBernardis, F., L. Agatensi, I. K. Ross, G. W. Emerson, R. Lorenzini, P. A. Sullivan, and A. Cassone. 1990. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161:1276-1283.
9. DeBernardis, F., P. Chiani, M. Ciccozzi, G. Pellegrini, T. Ceddia, G. D'Offizzi, I. Quinti, P. A. Sullivan, and A. Cassone. 1996. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun. 64:466-471.
10. El-Maghrabi, E. A., D. M. Dixon, and J. W. Burnett. 1990. Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherence to keratinocytes. Clin. Exp. Dermatol. 15:183-191.
11. Fallon, K., K. Bausch, J. Noonan, E. Huguenel, and P. Tamburini. 1997. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun. 65:551-556.
12. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
13. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
14. Ghannoum, M. A., and K. Abu Elteen. 1986. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol. 24:407-413.
15. Goldman, R. C., D. J. Frost, J. O. Capobianco, S. Kadman, R. R. Rasmussen, and C. Abad-Zapatero. 1995. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall β-glucan synthesis. Infect. Agent. Dis. 4:228-247.
16. Gow, N. A. R., P. W. Robbins, J. W. Lester, A. J. P. Brown, W. A. Fonzi, T. Chapman, and O. S. Kinsman. 1994. A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism or virulence of Candida albicans. Proc. Natl. Acad. Sci. USA 91:6216-6220.
17. Hoegl, L., M. Ollert, and H. C. Korting. 1996. The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J. Mol. Med. 74:135-142.
18. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7:55.
19. Hube, B., M. Monod, D. A. Schofield, A. J. P. Brown, and N. A. R. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14:87-99.
20. Hube, B., D. Sanglard, M. Monod, A. J. P. Brown, and N. A. R. Gow. 1997. Extracellular proteolytic activity of Candida species, p. 109-122. In H. Vanden Bossche, D. A. Stevens, and F. C. Odds (ed.), Host-fungus interplay. Proceedings of the Fifth Symposium on Topics in Mycology 1995. National Foundation for Infections Diseases, Bethesda, Md.
21. Hube, B., C. J. Turver, F. C. Odds, H. Eiffert, G. J. Boulnois, H. Köchel, and R. Rüchel. 1991. Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J. Med. Vet. Mycol. 29:129-132.
22. Ishiguro, A., M. Homma, T. Sukai, K. Higashide, S. Torii, and K. Tanaka. 1992. Immunoblotting analysis of sera from patients with candidal vaginitis and healthy females. J. Med. Vet. Mycol. 30:281-292.
23. Jaton-Ogay, K., S. Paris, M. Huerre, M. Quadroni, R. Falchetto, G. Togni, J. P. Latge, and M. Monod. 1994. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol. Microbiol. 14:917-928.
24. Kaminishi, H., H. Hamatake, T. Cho, T. Tamaki, N. Suenaga, T. Fujii, Y. Hagihara, and H. Maeda. 1994. Activation of blood clotting factors by microbial proteinases. FEMS Microbiol. Lett. 121:327-332.
25. Kaminishi, H., M. Tanaka, T. Cho, H. Maeda, and Y. Hagihara. 1990. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect. Immun. 58:2139-2143.
26. Kirsch, D. R., and R. R. Whitney. 1991. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect. Immun. 59:3297-3300.
27. Köhler, J. R., and G. R. Fink. 1996. Candida albicans strains heterozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc. Natl. Acad. Sci. USA 93:13223-13228.
28. Kurtz, M. B., M. W. Cortelyou, and D. R. Kirsch. 1986. Integrative transformation of Candida albicans, using a cloned Candida ADE2 gene. Mol. Cell. Biol. 6:142-149.
29. Kwon-Chung, K. J., D. Lehman, C. Good, and P. T. Magee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49:571-575.
30. Leberer, E., D. Harcus, I. D. Broadbent, K. L. Clark, D. Dignard, K. Ziegelbauer, A. Schmidt, N. A. R. Gow, A. J. P. Brown, and D. V. Thomas. 1996. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. USA 93:13217-13222.
31. MacDonald, F., and F. C. Odds. 1980. Inducible proteinase of Candida albicans in diagnostic serology and the pathogenesis of systemic candidosis. J. Med. Microbiol. 13:423-435.
32. MacDonald, F., and F. C. Odds. 1983. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129:431-438.
33. Magee, B. B. 1994. Formation of Candida spheroplasts, p. 113-115. In B. Maresca and G. S. Kobayashi (ed.), Molecular biology of pathogenic fungi. Telos Press, New York, N.Y.
34. Magee, B. B., B. Hube, R. J. Wright, P. J. Sullivan, and P. T. Magee. 1993. The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members. Infect. Immun. 61:3240-3243.
35. Manning, M., C. B. Snoddy, and R. A. Fromtling. 1984. Comparative pathogenicity of auxotrophic mutants of Candida albicans. Can. J. Microbiol. 30:31-35.
36. Matthew, R. C. 1994. Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology 140:1505-1511.
37. Miyasaki, S. H., T. C. White, and N. Agabian. 1994. A fourth secreted aspartyl proteinase gene (SAP4) and a CARE2 repetitive element are located upstream of the SAP1 gene in Candida albicans. J. Bacteriol. 176:1702-1710.
38. Monod, M., and D. Sanglard. 1996. Unpublished data.
39. Monod, M., S. Paris, J. Sarfati, K. Jaton-Ogay, P. Ave, and J. P. Latge. 1993. Virulence of alkaline proteinase-deficient mutants of Aspergillus fumigatus. FEMS Microbiol. Lett. 80:39-46.
40. Monod, M., G. Togni, B. Hube, and D. Sanglard. 1994. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol. Microbiol. 13:357-368.
41. Morrow, B., T. Srikantha, and D. R. Soll. 1992. Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans. Mol. Cell. Biol. 12:2997-3005.
42. Morrow, B., H. Ramsey, and D. R. Soll. 1994. Regulation of phase-specific genes in the more general switching system of Candida albicans strain 3153A. J. Med. Vet. Mycol. 32:287-294.
43. Odds, F. C. 1988. Candida and candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London, United Kingdom.
44. Odds, F. C. 1992. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. Antimicrob. Agents Chemother. 36:1727-1737.
45. Odds, F. C. 1994. Candida species and virulence. ASM News 60:313-318.
46. Ollert, M. W., R. Söhnchen, H. C. Korting, U. Ollert, S. Bräutigam, and W. Bräutigam. 1994. Mechanism of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61:4560-4568.
47. Perfect, J. 1996. Fungal virulence genes as targets for antifungal chemotherapy. Antimicrob. Agents Chemother. 40:1577-1583.
48. Polak, A. 1992. Virulence of Candida albicans mutants. Mycoses 35:9-16.
49. Ray, T. L., and C. D. Payne. 1987. Detection of Candida acid proteinase (CAP) antibodies in systemic candidiasis by enzyme immunoassay. Clin. Res. 35:711A.
50. Ross, I. K., F. DeBernardis, G. W. Emerson, A. Cassone, and P. A. Sullivan. 1990. The secreted aspartatc proteinase of Candida albicans: physiology of secretion and virulence of a proleinase-deficient mutant. J. Gen. Microbiol. 136:687-694.
51. Rüchel, R. 1981. Properties of a purified proteinase from the yeast Candida albicans. Biochim. Biophys. Acta 659:99-113.
52. Rüchel, R. 1992. Proteinase, p. 17-31. In J. E. Bennett, R. J. Hay, and P. K. Peterson (ed.), New strategies in fungal disease. Churchill Livingstone, Edinburgh, Scotland.
53. Rüchel, R., B. Böning-Stutzer, and A. Mari. 1988. A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data. Mycoses 31:87-106.
54. Rüchel, R., K. Uhlemann, and B. Böning. 1983. Secretion of acid proteinases by different species of the genus Candida. Zentralbl. Bakteriol. Hyg. I Abt. Orig. A 255:537-548.
55. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
56. Sanglard, D., B. Hube, M. Monod, F. C. Odds, and N. A. R. Gow. 1997. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun. 65: 3539-3546.
57. Shepherd, M. G. 1985. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections. Infect. Immun. 50: 541-544.
58. Smolenski, G., P. A. Sullivan, S. M. Cutfield, and J. F. Cutfield. 1997. Analysis of secreted aspartic proteinases from Candida albicans: purification and characterization of individual Sap1, Sap2, and Sap3 isoenzymes. Microbiology 143:349-356.
59. Srikantha, T., B. Morrow, K. Schröppel, and D. Soll. 1995. The frequency of integrative transformation at phase-specific genes of Candida albicans correlates with their transcriptional state. Mol. Gen. Genet. 245:342-352.
60. Tang, C. M., J. Cohen, T. Krausz, S. Van Noorden, and D. W. Holden. 1993. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect. Immun. 61:1650-1656.
61. Tsushima, H., H. Mine, Y. Kawakami, F. Hyodoh, and A. Ueki. 1994. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 140:167-171.
62. Tsushima, H., and H. Mine. 1995. Cleavage of human big endothelin-1 by Candida albicans aspartic proteinase. FEMS Immunol. Med. Microbiol. 11: 69-72.
63. White, T. C., and N. Agabian. 1995. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J. Bacteriol. 177:5215-5221.
64. White, T. C., S. H. Miyasaki, and N. Agabian. 1993. Three distinct secreted aspartyl proteinases in Candida albicans. J. Bacteriol. 175:6126-6133.
65. Wright, R. J., A. Carne, A. D. Hieber, I. L. Lamont, G. W. Emerson, and P. A. Sullivan. 1992. A second gene for a secreted aspartate proteinase in Candida albicans. J. Bacteriol. 174:7848-7853.
66. Wu, T., L. P. Samaranayake, B. Y. Cao, and J. Wang. 1996. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infections and its attenuation by antimycotic agents. J. Med. Microbiol. 44:311-316.